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DNA Methylation Patterns in Cord Blood of
Neonates Across Gestational Age
Association With Cell-Type Proportions
SusanM. Braid ▼ KwameOkrah ▼ Amol Shetty ▼ Hector Corrada Bravo
Background: A statistical methodology is available to estimate the proportion of cell types (cellular heterogeneity) in adult whole
blood specimens used in epigenome-wide association studies (EWAS). However, there is no methodology to estimate the
proportion of cell types in umbilical cord blood (also a heterogeneous tissue) used in EWAS.
Objectives: The objectives of this study were to determine whether differences in DNAmethylation (DNAm) patterns in umbilical
cord blood are the result of blood cell type proportion changes that typically occur across gestational age and to demonstrate the
effect of cell type proportion confounding by comparing preterm infants exposed and not exposed to antenatal steroids.
Methods:We obtained DNAm profiles of cord blood using the Illumina HumanMethylation27k BeadChip array for 385 neonates
from the Boston Birth Cohort. We estimated cell type proportions for six cell types using the deconvolution method developed by
Houseman et al. (2012).
Results: The cell type proportion estimates segregated into two groups that were significantly different by gestational age,
indicating that gestational age was associated with cell type proportion. Among infants exposed to antenatal steroids, the
number of differentially methylated CpGs dropped from 127 to 1 after controlling for cell type proportion.
Discussion: EWAS utilizing cord blood are confounded by cell type proportion. Careful study design including correction for cell
type proportion and interpretation of results of EWAS using cord blood are critical.
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Epigenome-wide association studies (EWAS) are in-creasingly being used to investigate birth weight,prematurity, and exposures in neonates with the
hope of providing insight into molecular differences so that
interventions can be developed. These studies utilize umbilical
cord blood to measure DNA methylation (DNAm; Chen et al.,
2014; Kile et al., 2014; Lee et al., 2012; Liu et al., 2014; Remy
et al., 2014), but most of these studies do not take into account
the fact that umbilical cord blood, like adult blood, is a hetero-
geneous tissue (Blackburn, 2013). For example, the propor-
tion of leukocytes can vary depending on age, disease status,
and other variables that impact the immune system. This
means that any DNAm differences may be confounded by dif-
ferences in the cellular proportions of the umbilical cord
blood samples because EWAS may yield associations that are
false positives; that is, findings may be the result of cell type
proportion differences rather than an exposure of interest. Re-
searchers have recognized that cellular heterogeneity is a sig-
nificant issue for EWAS utilizing adult whole blood specimens,
developed specialized statistical methods to account for that
heterogeneity, and adapted those methods as tools for epige-
netic research continue to evolve (Jaffe & Irizarry, 2014).
In a seminal paper, Houseman et al. (2012) developed
an algorithm to estimate the proportion of immune cells
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in adult whole blood by identifying differentially methyl-
ated DNA regions (DMRs) for each of the principal immune
components of whole blood—granulocytes, monocytes,
and some subpopulations of lymphocytes (CD4 T cells, CD8
T cells, natural killer [NK] cells, and B cells). Using the Illumina
HumanMethylation27k BeadChip Microarray (Illumina, Inc.,
San Diego, CA), the authors identified 500 CpG sites that are
specific to these cell types and provided new analytical
tools for estimating cell type proportions in EWAS. Despite
the availability of this algorithm, few researchers have at-
tempted to address potential confounding from cell type het-
erogeneity in their EWAS analyses in umbilical cord blood.
Three research teams have used the methodology cre-
ated by Houseman et al. (2012) to examine the impact of
exposures and DNAm while controlling for blood cell type
proportions in cord blood. Most recently, the methodology
was used to demonstrate that in utero arsenic exposure in
term and preterm infants was associated with altered
DNAm patterns after controlling for leukocyte proportions;
in utero arsenic exposure had a dose-dependent effect on
certain T-cell subpopulations in umbilical cord blood (Kile
et al., 2014). A similar approach was used when studying
DNAm patterns and birth weight in both term and preterm
infants (Engel et al., 2014). Deconvolution analysis was also
used to infer changes in the distribution of leukocytes in a
study of arsenic exposure in utero and cord blood DNAm
in term infants (Koestler, Avissar-Whiting, Houseman,
Karagas, & Marsit, 2013). These research teams all used
the methodology created by Houseman et al. (2012), in-
cluding the reference data set comprising only adult periph-
eral blood samples; several noted that it is unclear whether
this methodology is sufficient for correcting the cell-
specific patterns of DNAm in umbilical cord blood.
The methodology developed by Houseman et al. (2012)
may not be sufficient for leukocyte proportion adjustment
whenanalyzing cordbloodbecausebloodcell typeproportion
changes naturally across gestational age.DNAm levels aremea-
sured on nucleated cells, and in cord blood, most of the cells
with nuclei are the cells of the immune system (i.e., mono-
cytes neutrophils, eosinophils, basophils, B cells, NK cells,
and T cells). Because immunological changes occur in gesta-
tion, cord blood cell type proportions fluctuate greatly through-
out fetal development and may vary significantly depending
on the gestational age of the infant (Koenig & Yoder, 2004;
Maheshwari & Christensen, 2004; Segel & Palis, 1995; Ygberg
& Nilsson, 2012). Granulocytes (Remington, Klein, Wilson,
Nizet, & Maldonado, 2001), CD4 T cells (Chabra et al., 1998;
Duijts et al., 2009), and B cells (Correa-Rocha et al. 2012;
Thilaganathan, Nicolaides, Mansur, Levinsky, & Morgan, 1993)
increase during gestation, whereas NK cells vary throughout
gestation (Correa-Rocha et al., 2012; Pérez, Gurbindo, Resino,
Aguarón, & Muñoz-Fernández, 2007; Peoples et al., 2009;
Ygberg & Nilsson, 2012). If cord blood cell type proportion
differences between samples account for a certain amount
of the overall DNAm variability, then cell type proportion fluc-
tuations across gestational age should significantly affect
DNAm findings.
As researchers continue to analyze the impact of environ-
mental exposures on the fetal epigenome by studying cord
blood, it is critical that we clarify whether cell type proportion
is confounding findings. We hypothesize that researchers an-
alyzing the DNAm of cord blood without correction for cell
type proportions will identify differentially methylated CpGs,
which they may attribute to an environmental exposure, when
in fact, those differences between DNAm patterns may exist
only because of cell type proportion changes across gestational
age. Therefore, the objective of this study was to determine
whether differences in DNAm patterns in umbilical cord blood
are the result of blood cell type proportion changes that occur
naturally across gestational age and to highlight the potential
for confounded results by comparing a sample of preterm in-
fants whowere exposed and not exposed to antenatal steroids.
In this study, we used Houseman et al.’s (2012) de-
convolution methodology to analyze the DNAm profiles of
cord blood for 385 term and preterm infants from the Boston
Birth Cohort, ranging from 30 to 44 weeks in gestational
age. The aims were to:
1. measure the amount of overall DNAm variability that may be
accounted for by differences in cell type proportions in the
umbilical cord blood of term and preterm infants, relative to
differences in gestational age and gender;
2. estimate cell type proportions for six cell types (granulocytes,
monocytes, B cells, NK cells, CD4 T cells, and CD8 T cells)
and identify differences in cell type proportion patterns across
gestational age; and
3. determine if an analysis of the cord blood of preterm infants
(gestational ages 30–36 weeks) exposed and not exposed to
antenatal steroids reveals differences in DNAm patterns and
whether some or all of those patterns can be explained by dif-
ferences in cell type proportions as an illustrative example of
potential confounding.
Glucocorticosteroids are a common exposure in pre-
term infants, and yet, research indicates that steroid appli-
cation is associated with changes in DNAm (Carreno
et al., 2011; Romero, Dey, & Fisher, 2014). The question
is whether controlling for cell type proportions would im-
pact this finding. As far as we are aware, this is the first
study to use the DMRs identified by Houseman et al.
(2012) to investigate how umbilical cord blood cell type
proportion changes over gestation.
METHODS
Study Sample
The sample for this studywas taken fromanongoing study called
the Boston Birth Cohort (BBC) that enrolls mother–infant
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pairs from Boston Medical Center at birth and follows them
prospectively. We studied a subsample of 385 African
American, Haitian, or Cape Verdean mother–infant pairs; ges-
tational ages ranged from 25 and 44 weeks. Cord blood was
collected from all births at the time of delivery by trained nurs-
ing staff. Maternal interviews were conducted using a struc-
tured questionnaire. Gestational age was assessed with an
algorithm based on the last menstrual period and early ultra
sound before 20 weeks gestation. Further details concern-
ing BBC design and methodology are available in D. Wang
et al. (2012) and X. Wang et al. (2002).
Maternal consent was obtained for all cohort participants.
The BBC was approved by the Boston Medical Center and
Johns Hopkins University Institutional Review Boards. This
study was approved by the University of Maryland Institu-
tional Review Board.
DNAm Data Preprocessing
We obtained DNAm profiles of cord blood using the Illumina
HumanMethylation27k BeadChip (Illumina, Inc.) array for
385 neonates from the BBC. Only probes in autosomes were
used to avoid bias from large differences in sex chromosomes.
Arrays with low total signal were filtered as part of quality as-
sessment. We detected a strong batch effect for one of the
27k arrays and removed samples from that array.We restricted
samples to those over 30weeks of gestational agebecauseonly
six samples were less than 30 weeks. After filtering the cord
blood samples for total signal and batch correction, we
dropped 38 samples, including some from infants born at later
gestational ages because of quality assurance issues; we
retained 341 samples, ranging from 30 to 43weeks gestational
age. Methylated and unmethylated signals were each quantile
normalized across arrays using a modification of the minfi
package (Aryee et al., 2014). We used the Illumina-provided
annotation for the 27k BeadArray (HumanMethylation27
270596 v.1.2.bpm). All analyses were performed on methyla-
tion percentages computed after quantile normalization—
except where noted.
Blood Cell Type-Specific CpGs
We obtained the top 500 CpGs for the 27k array that distinguish
cell types in adult blood as described in Houseman et al. (2012)
and implemented in code provided by that group using version
112 (http://people.oregonstate.edu/~housemae/software/).
Hierarchical Clustering
Weperformed hierarchical clustering analysis using Euclidean
distance onmethylation log ratio (M values) and estimated cell
type estimates. Using both a two-sided t-test with unequal var-
iance and a Wilcoxon rank-sum test, we completed tests for
difference in gestational age across clusters, segregating sam-
ples according to the first partition obtained by hierarchical
clustering. Tests for difference in variance on these two
groups of samples were performed using an F-test.
Cell Type Proportion Estimation
We estimated cell type proportions for six cell types
(granulocytes, monocytes, B cells, NK cells, CD4 T cells, and
CD8 T cells) using Houseman et al.’s (2012) deconvolution
method. We used the top 500 cell-specific CpGs as determined
above and themethylationprofiles provided byHousemanet al.
for cell-sorted samples of adult blood. This method esti-
mates a proportion of each cell type within each sample
(i.e., interpreted as the proportion of cells of that type in
each cord blood sample).
Statistical Analyses
Methylation DifferencesWe used statistical methods devel-
opedbyHousemanet al. (2012) to studymethylation in this co-
hort. We defined a mixed effects model of DNAm percentage
for eachCpG and cord blood sample, using gestational age and
gender as fixed effects and proportion of each cell type (esti-
mated as above) as random effects. We used variance compo-
nents analysis to determine the percentage of total variation
that is systematic (explainedbyboth fixed and randomeffects)
and the percentage of systematic variation explained by cell
type proportions (explained by random effects). As part of this
analysis, we estimatemodel parameters that summarize the as-
sociation between cell type proportion on gestational age as
described in Houseman et al. (2012).
Antenatal Steroid ApplicationWeobtaineddata on antena-
tal steroid use for 60 preterm infants in our cohort; 19 of those
infants were administered antenatal steroids. Their gestational
ages ranged from 30 to 36 weeks. We used logistic regression
to determine association betweenantenatal steroid administra-
tion and (a) gestational age, (b) infant gender, (c) granulocyte
proportion, and (d)CD4T-cell proportion. The latter twowere
estimated from DNAm measurements using the Houseman
et al. (2012) deconvolution method and then transformed
using an inverse logit transformation. All numerical covariates
were centered and scaled for this analysis. We then fit a linear
model regressing DNAm log ratio on antenatal steroid appli-
cation and an interaction term between gestational age and
CD4 T-cell proportion as above. We used empirical Bayes
methods to shrink variance estimates across CpGs, and a
moderated t-test was performed to determine differentially
methylated CpGs, using the minfi package (Aryee et al.,
2014). CpGs were reported as differentially methylated at
1% false discovery rate.
RESULTS
Detailed statistical results are available (see Figures, Supple-
mental Digital Content 1, http://links.lww.com/NRES/A236).
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Changing Cell Type Proportions Across Gestational Age
After using the deconvolution method and performing cluster
analysis on the resulting cell type proportion estimates, we ob-
served that samples segregated into two groups based on cell
type proportions (Figure 1A). One cluster is generally com-
posed of granulocyte-rich samples; the other is generally com-
posed of granulocyte-poor samples. There is also a significant
difference in gestational age between samples in the two clusters
(Figure 1B), with a mean of 39.0 (SD = 1.85) and 37.6 weeks
(SD = 2.59) on the granulocyte-rich and -poor samples, re-
spectively (t-test: p = .000001; Wilcoxon rank sum test:
p = .000002), suggesting that differences in gestational
age are associated with blood cell type proportions. The
cell type proportions of the cluster corresponding to later
gestational age is dominated by granulocytes, whereas the
cluster corresponding to earlier gestational age is character-
ized by diminished presence of granulocytes and increased
CD4 T cells, B cells, and NK cells (Figure 1A). Gestational
age variability differed within each of the two clusters; the
cluster corresponding to later gestational age had significantly
lower variance (SD = 1.85 vs. 2.59; F-test: p = .000006).
The regression analysis revealed the dynamics of cell type
proportions in cord blood (as estimated by DNAm in cell type
specific CpGs) when examined across a range of gestational
age groups (Table 1; Figure 1C and D; also see Figures, Supple-
mental Digital Content 2, http://links.lww.com/NRES/A237).
FIGURE1. Differences in cell type proportions in cord blood are associated with gestational age. (A) Heatmap of blood cell type proportions estimated from
DNAm for 341 neonate cord blood samples. Hierarchical clustering is based on blood cell type proportions; colors under the tree are used to indicate
clustering of subjects into two groups (corresponding to granulocyte rich vs. granulocyte poor samples). (B) Gestational age distribution of subject
clusters determined by blood cell type proportions (granulocyte rich or granulocyte poor). Granulocyte rich samples (blue) are predominantly full term;
granulocyte poor samples (red) are predominantly preterm. (C) Proportion of granulocytes by gestational age.Marker types indicate subject gender, indicating
no significant difference in proportion due to gender. (D) Proportion of CD4 T cell by gestational age. Marker types indicate subject gender, indicating no
significant difference in proportion due to gender.
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Granulocyte proportion varied most across gestational age;
theproportionnearly doubled from32 to 40weeks (Z-score=7.5;
p = 6.08e−14; see Figure 1C). The second largest effect was for
CD4 T cells, where the proportion dropped by half from 32
to 40 weeks (Z-score = −7.08; p = 1.37e−12; see Figure 1D).
We observed smaller effects on B cells and NK cells, where the
proportion decreased across gestation. No significant changes
were observed for monocytes and CD8 T cells in this cohort.
Explaining Methylation Variability After Accounting
for Gestational Age
We sought tomeasure the amount of overall DNAm variability
that may be accounted for by differences in cell type propor-
tions relative to differences in gestational age and gender. Fol-
lowing the methods described by Houseman et al. (2012), we
built a model including gestational age and gender as fixed ef-
fects, with estimated cell type proportion as a random effect,
as described in the Statistical Analysis. We obtained estimates
for total variation in methylation, along with an estimate of
systematic variation, which was partitioned into variation
explained by gestational age and gender and that explained
by cell type proportions. The percentage of total variation
explained by systematic variation was small (8.21%), but
the percentage of systematic variation explained by cell
type proportions was high (84.93%). This finding indicates
that, although systematic variation contributes modestly to
the total variation in methylation in this cohort, differences
in cell type proportions make up a significant percentage of
that variation. The percentages of DNAm variability ex-
plained by systematic variability and the percentages of sys-
tematic variability explained by cell type proportions are
similar to those reported by Houseman et al. (2012) in their
studies of adult cohorts.
Potential Confounding by Cell Type Proportions and
Gestational Age
When we investigated a subsample of 19 infants exposed to
antenatal steroids, along with 41 infants for which we had re-
cord of no exposure to antenatal steroids, we found a strong
association between antenatal steroid exposure and both
early gestational age (Table 2; Z-score = −3.27, p = .001) and
lower CD4 T-cell concentration (Z-score = −2.03, p = .04).
On the basis of this observation, we regressed themethylation
log ratio for each CpG on antenatal steroid exposure, gesta-
tional age, and CD4 T-cell concentration. We compared two
models to determine the association between antenatal steroid
exposure and differences in DNAm: onemodel controlling for
gestational age and CD4 T-cell concentration and one not con-
trolling for these.
When only considering antenatal steroid exposure in this
cohort, we found 127 CpGs that showed significant differ-
ences. On the other hand, only one CpG—in the promoter re-
gion of FRA10AC1—showed a significant difference in DNAm
when controlling for gestational age and CD4 T-cell concen-
tration. We observed that subjects who received antenatal
steroids had consistently higher methylation at similar ges-
tational age (Figure 2).
DISCUSSION
In this study,weobserved that cell type proportions in the um-
bilical cord blood of term and preterm infants explain a
TABLE 1. Association Between Gestational Age and Blood Cell
Type Proportions in Cord Blood
Cell type Estimate Z-score p Adjusted p
Intercept −0.115 −2.50 .01 .09
CD8 T 0.403 4.44 1e−05 6e−05
CD4 T −1.016 −7.09 0 0
NK −0.488 −4.20 3e−05 .0002
B −0.519 −5.83 0 0
Monocyte 0.04 0.56 .58 1
Granulocyte 1.747 7.51 0 0
Note. N = 341. NK = natural killer.
TABLE 2. Association Between Antenatal Steroid Application,
Gestational Age, Gender, and Cell Type Proportions in Cord
Blood
Term Estimate SE Z-score p
Intercept −0.775 0.485 −1.60 .11
Gestational age (weeks) −1.555 0.475 −3.27 .001
Gender (male) −0.646 0.749 −0.86 .39
Granulocyte (proportion) −0.784 0.499 −1.57 .12
CD4 T cell (proportion) −1.002 0.494 −2.03 .04
Note. N = 60. SE = standard error.
FIGURE 2. DNAm percentage for 60 neonate cord blood samples for
a CpG in the promoter region of FRA10AC1 by gestational age. DNAm
changes in promoter region of FRA10AC1 are associated with gestational
age and antenatal steroid application. Points in red correspond to samples
where antenatal steroids were applied. Points in black are samples
where no antenatal steroids were applied. Point size is proportional to
estimated proportion of CD4 T cells.
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significant portion of systematic variation in this cohort after
accounting for gestational age in analyses of DNAm patterns;
and although systematic variation only explains a modest por-
tion of totalmethylation variability, it is sufficient to affect find-
ings ofDNAmdifferences associated tophenotypes of interest.
Blood cell type methylation markers segregated the infant co-
hort by gestational age into two clusters: a cluster correspond-
ing to later gestational age and a cluster corresponding to
earlier gestational age. The clusters were characterized by dis-
tinct cord blood cell type proportion profiles based on propor-
tions of granulocytes, lymphocytes, and B cells. Some of our
findings are consistent with what is known about fetal cord
blood cell type proportions and its changes during gestation,
whereas others were unexpected.
The later gestational age cluster had significantly higher
numbers of granulocytes than did the earlier gestational age
cluster. This finding corresponds with the fact that normally
granulocytes increase rapidly in a fetusduring the last trimester
(Maheshwari & Christensen, 2004). The number of circulating
granulocytes is around 10% of the leukocyte population at
14–16weeks gestation and increases to 50%–60%by term. Pre-
vious research has also shown that preterm infants tend to have
a low proportion of granulocytes (Remington et al., 2001).
Lymphocyte proportion differed significantly between
the two clusters. CD4 T cells were more abundant in the clus-
ter corresponding to earlier gestational age, which was unex-
pected because these cells should typically increase as
gestational age increases. Studies investigating CD4 T cells in
preterm infants showed lower counts compared to term in-
fants (Chabra et al., 1998; Duijts et al., 2009). NK cells were
also more abundant in preterm infants than in term infants.
The literature has mixed findings for NK cell numbers during
gestation. NK cells have been found to increase over gestation
(Correa-Rocha et al., 2012; Pérez et al., 2007) and correlate
with gestational age (Ygberg & Nilsson, 2012). However,
Peoples et al. (2009) found increased NK cells in preterm in-
fant cord blood compared to term infant cord blood.
B cells were more abundant in the early gestational age
cluster than in the late gestational age cluster, another unex-
pected finding. Correa-Rocha et al. (2012) found lower abso-
lute counts of B cells in preterm infants, and there was a
positive correlation with gestational age and birth weight.
The total number of B cells exponentially increases over gesta-
tion and remains stable after 36 weeks (Thilaganathan et al.,
1993) and are abundant at birth (Ygberg & Nilsson, 2012).
There are a number ofpotential explanations forwhyCD4
T, NK, and B cells were more abundant in the earlier gesta-
tional age cluster than in the later gestational age cluster in this
sample. First, the proportion of granulocytes is significantly
lower in the cord blood of preterm infants, making selection
of other cell types during sampling more likely. The propor-
tion of granulocytes compared to CD4 T, NK, and B cells
may be higher in later gestational age but may not affect the
absolute value of CD4 T, NK, and B cells. Second, the higher
numbers of NK cells in the cord blood of the cluster associated
with earlier gestational age may be the result of inflamma-
tion. Research indicates that congenital infection in the sec-
ond trimester is associated with an increased count of NK
cells (Remington et al., 2001). Infection and inflammation
are regarded as one of the most important and potentially
preventable causes of preterm birth (Burdet et al., 2014;
Kallapur, Presicce, Rueda, Jobe, & Chougnet, 2014; Romero
et al., 2014), but this biological mechanism would not ex-
plain the higher numbers of CD4 T and B cells. Third, a
number of exposures experienced by preterm infants can also
independently influence cord blood cell type proportions and
may explain some of our unexpected study findings, as well
the higher variability in blood cell type proportion in the clus-
ter corresponding to earlier gestational age (Carreno et al.,
2011; Romero et al., 2014). For example, fetal exposure toma-
ternal smoking is associatedwith normal to higher counts of T
cells (Remington et al., 2001).
Our analysis of antenatal steroid exposure demonstrates
how the relationship between cell type proportions and gesta-
tional age can confound analyses of an epigenetic response to
an exposure. The number of CpGs showing significant DNAm
associated with antenatal steroid application in this cohort
was reduced from 137 to a single CpG when controlling for
gestational age and blood cell type proportions. This suggests
thatwhen the outcome under study, in this case, antenatal ste-
roid exposure, correlates with gestational age and cell type
proportions—an analysis without proper controls results in
many false positives. Antenatal steroids are glucocorticoid ste-
roids that have been found to be associated with changes in
DNAm on specific genomic sites in rat models (Ewald et al.,
2014). To the best of our knowledge, FRA10AC1 has not been
reported in the literature as a specific site affected by gluco-
corticoid steroids. Hypermethylation in the region FRA10A
C1 serves to counteract folate-sensitive fragility (Sarafidou
et al., 2004). Our observation of increased methylation in this
region associated with antenatal steroid application suggests
that further investigation of the association between hyper-
methylation and genomic instabilities associated with deple-
tion of folic acid and the role of antenatal steroids in this
mechanism should be further explored.
Strengths and Limitations
Themain strength of this study is that the BBC has a large sam-
ple size of preterm births, and a substantial number of umbili-
cal cord blood samples were collected and analyzed using
the Illumina HumanMethylation27k BeadChip. The main limi-
tation of this study is that theDMRsweused to identify individ-
ual blood cell types were developed using a reference
population of adult peripheral blood samples (see Houseman
et al., 2012). We used this methodology because there are cur-
rently no specific DMRs identified for umbilical cord blood.
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The lymphocyte subtypes in cord blood may have different
DNAm patterns because T-cell lineage epigenetically changes
at midgestation during fetal development (Basha, Surendran,
& Pichichero, 2014). It is possible that by utilizing the
Houseman et al. (2012) correction, we did not identify all of
the differences in cell type proportions that may occur across
gestational age. It will be important to replicate this study once
an umbilical cord blood correction is published.
Contributions to Nursing Science
Our study adds to nursing science by further elucidating the
complexities involved in performing epigenetic research.
Epigenetic researchers are still developing and refining
methodologies, such as the cell type proportion correction
we are suggesting that may be needed for the epigenetic
analysis of umbilical cord blood. Nurses are actively in-
volved in epigenetic research on a variety of health issues
including pain, cardiovascular disease, childbirth, obesity,
and metabolic syndrome and will continue to participate
in the advancement of science. Understanding the latest ad-
vancements in this fast-developing field will be critical in
conducting and advancing epigenetic research. Nurses play
a key role in epigenetic research because of their unique in-
sights into patients of all ages. This insight and rigorous re-
search driven by multidisciplinary teams including nurses
will help move the evolving science of epigenetics forward.
Conclusion
Our analysis suggests that systematic variance accounts for
8.21% of total variation; of this, cell type proportions explains
84.93% of the systematic variation in DNAm of the umbilical
cord blood in this cohort. Researchers utilizing umbilical cord
blood to perform EWAS must consider cord blood cell type
proportion variability; however, the statistical methods cur-
rently used for studies based on adult whole blood are insuffi-
cient for this purpose. New statistical methods are needed to
account for the complexities of the cellular proportions of
cord blood—particularly preterm infant cord blood—which
would need to include the presence of certain cell types, such
as stem cells and nucleated red blood cells. EWAS have great
potential to improve our understanding of the impact of expo-
sures on the fetal epigenome, but we must develop appropri-
ate statistical methods and conduct carefully designed studies
in order to continue making significant progress.
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